Keywords: Novartis, Russia, Investment, Manufacturing plant, Research collaborations, Investment

Novartis plans $500 million investment in Russia, including drug-making plant

Article | 20 December 2010

Print This

Swiss drug major Novartis (NOVN: VX) this morning announced the signing of a Memorandum of Understanding (MoU), confirming its intent ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in